We never compromise
on quality.

Rubicon Research Manufacturing Site in Ambernath, India

Rubicon Research’s world-class Ambernath plant is focused on producing pharmaceutical products (Rx as well as over the counter), and supports scale up and commercialization in a range of oral solids.

The 140,000+ square feet state-of-the-art manufacturing plant is compliant with US FDA and EU specifications, with 43,500 square feet of the entire area specially devoted to cGMP manufacturing. It has capabilities across powders, granules, pellets, dispersible tablets, orally disintegrating tablets, controlled/modified release tablets and hard gelatin capsules. The products manufactured are non-toxic, non-hormonal, non-steroidal, non-beta lactam and non-sensitizing.

Manufacturing Capacity

Capacity (Million Units) Current By Q2 2020
Compression 2,000 3,000
Coating 1,600 2,500
Blister Packing 1,200 1,200
Capsule Filling 1,000 1,500
Bottle Packing 2,500 3,500

Our Regulatory Accreditations :

To request for our equipment list, drop us an email at bd@rubicon.co.in